✓
No active regulatory warnings
Sources: FDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
1 Identity
Tejocote Root
Crataegus mexicana (Mexican Hawthorn root)
Use with CautionEvidence: LimitedRestrictedTejocote root (Crataegus mexicana) is a Mexican weight-loss supplement that has caused MULTIPLE DEATHS due to contamination with yellow oleander (Thevetia peruviana / Cascabela thevetica) — a plant containing cardiac glycosides (thevetin A/B) [1]. FDA has issued multiple warnings about Alipotec® and Elke® brand tejocote root products found to contain yellow oleander instead of or in addition to actual tejocote. Symptoms mimic digitalis toxicity: bradycardia, heart block, hyperkalemia, death. This is not a quality-control issue — it is a lethal adulteration/substitution [1].
2 Risk self-assessment
HIGH RISK — see overview [1].
Select factors above to see your risk level
4 Lab interpreter
See overview
Your level:
Enter a value above
⚕ For healthcare professionals. Does not replace clinical judgment.
5 Quick facts
CategoryRestricted
Safety levelUse with Caution
EvidenceLimited
RDATypical 1 piece/day (marketed dose)
Upper limit (UL)No UL established
Scientific nameCrataegus mexicana (Mexican Hawthorn root)
HIGH RISK — see overview[1]
6 Dosage by population
Adults Moderate
See product label
Elderly Moderate
See product label
Consider reduced renal/hepatic clearance. Start at lower end of range.
Athletes Limited
Standard dose
Obesity Limited
Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
Renal Limited
Consult specialist
Dose adjustment may be needed in renal impairment.
Vegan Moderate
Standard dose
HIGH RISK ingredient — see overview for safety concerns [1].
7 Form comparison
| Form | Bioavailability | Vegan | Cost/day |
|---|---|---|---|
| ['Various', 'see overview', 'See overview for forms and risks [1].'] | Standard | Check label |
8 Clinical evidence
Strong evidence
See overview [1]. HIGH
Moderate evidence
See overview [1]. MODERATE
Insufficient evidence
See overview [1]. LOW
9 Safety
🚩 Red flags — when to stop and refer
● HIGH RISK — see overview for critical safety alerts [1]
Pregnancy
ABSOLUTELY CONTRAINDICATED — cardiac glycoside poisoning risk [1].
Pediatric
Not recommended [1].
10 Toxicity and overdose
11 Drug interactions
12 Supplement interactions
13 Laboratory monitoring
14 Deficiency and prevalence
Risk factors
• HIGH RISK — see overview [1].
15 Frequently asked questions
Key safety point ▼
Tejocote root products are KILLING PEOPLE through contamination with yellow oleander (cardiac glycoside). Multiple FDA warnings, poison control cases, and deaths. The cardiac glycosides (thevetin A/B) cause digitalis-like toxicity: bradycardia, heart block, hyperkalemia, cardiac arrest. This is not a 'side effect' — it is POISONING from plant misidentification or deliberate substitution. ALL commercially available tejocote root weight-loss products should be considered potentially contaminated until proven otherwise [1].
16 Regulatory status
See overview for regulatory status: [1].
17 References
[1]FDA. FDA advises consumers to stop using certain tejocote root products marketed for weight loss. Safety Alert. 2022. GOVERNMENT
[2]Eddleston M, et al. Thevetia peruviana poisoning: an evidence-based treatment protocol. Clin Toxicol. 2000;38(4):431-436. REVIEW
18 Related articles
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
Auto-updated from GMJ Newsroom. Articles tagged "Tejocote Root" appear here.
19 Cite this page
Vancouver
Pkhakadze G. Tejocote Root — safety profile [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/ingredients/tejocote-root/
APA 7th
Pkhakadze, G. (2026). Tejocote Root — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/tejocote-root/
CC BY 4.0
🛡 SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
GP
Reviewed by Prof. G. Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, PHIG
Last reviewed: May 2026 · Next: November 2026
This entry is provided for educational and public health purposes under CC BY 4.0. Consult your healthcare provider before starting any supplement. For corrections: info@accreditation.ge.
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD